Cargando…
Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome
BACKGROUND: Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is an innate-immune receptor found in blood. Its presence reflects innate immune cell activation. We sought to investigate plasma sTREM-1 levels in patients with primary antiphospholipid syndrome (PAPS). METHODS: A cross-...
Autores principales: | Edel, Yonatan, Kliminski, Vitaly, Pokroy-Shapira, Elisheva, Oren, Shirly, Dortort Lazar, Ariela, Pri-Paz Basson, Yael, Egbaria, Mohammad, Molad, Yair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323669/ https://www.ncbi.nlm.nih.gov/pubmed/30616644 http://dx.doi.org/10.1186/s13075-018-1779-5 |
Ejemplares similares
-
Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome
por: Shiber, Shachaf, et al.
Publicado: (2021) -
Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003) -
Pediatric Deep Venous Thrombosis and Pulmonary Embolism: Can It Be Antiphospholipid Syndrome?
por: Demir Yenigürbüz, Fatma, et al.
Publicado: (2019) -
COVID-19, Antiphospholipid Syndrome and Thrombosis
por: Yasri, Sora, et al.
Publicado: (2020) -
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022)